Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42

ACS Chemical Neuroscience

Volumn 3, Issue 9, 2012, Pages 674-681

  Izuo, Naotaka ^a   Kume, Toshiaki ^a   Sato, Mizuho ^a   Murakami, Kazuma ^a   Irie, Kazuhiro ^a   Izumi, Yasuhiko ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimers disease; amyloid ; neurotoxicity; oxidative stress; toxic conformer; turn structure

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; REACTIVE OXYGEN METABOLITE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BETA TURN; CELL STRESS; CONTROLLED STUDY; NEUROTOXICITY; NONHUMAN; OLIGOMERIZATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CHROMANS; CONGO RED; FEMALE; FREE RADICAL SCAVENGERS; MUTATION; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PREGNANCY; PROTEIN CONFORMATION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES; VITAMIN E;

RATTUS;

EID: 84866397329     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300033k     Document Type: Article

References (45)

1. Selkoe, D. J. (1998) The cell biology of β-amyloid precursor protein and presenilin in Alzheimers disease Trends Cell Biol. 8, 447-453
2. Iwatsubo, T., Mann, D. M., Odaka, A., Suzuki, N., and Ihara, Y. (1995) Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome Ann. Neurol. 37, 294-299
3. Haass, C. and Selkoe, D. J. (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimers amyloid β-peptide Nat. Rev. Mol. Cell Biol. 8, 101-112 (Pubitemid 46432529)
4. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453
5. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416, 535-539 (Pubitemid 34288854)
6. Barnham, K. J., Masters, C. L., and Bush, A. I. (2004) Neurodegenerative diseases and oxidative stress Nat. Rev. Drug Discovery 3, 205-214
7. Butterfield, D. A. (2003) Amyloid β-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimers disease brain: mechanisms and consequences Curr. Med. Chem. 10, 2651-2659 (Pubitemid 37456035)
8. Murakami, K., Irie, K., Ohigashi, H., Hara, H., Nagao, M., Shimizu, T., and Shirasawa, T. (2005) Formation and stabilization model of the 42-mer Aβ radical: implications for the long-lasting oxidative stress in Alzheimers disease J. Am. Chem. Soc. 127, 15168-15174 (Pubitemid 41547384)
9. Masuda, Y., Uemura, S., Ohashi, R., Nakanishi, A., Takegoshi, K., Shimizu, T., Shirasawa, T., and Irie, K. (2009) Identification of physiological and toxic conformations in Aβ42 aggregates ChemBioChem 10, 287-295
10. Irie, K., Murakami, K., Masuda, Y., Morimoto, A., Ohigashi, H., Hara, H., Ohashi, R., Takegoshi, K., Fukuda, H., Nagao, M., Shimizu, T., and Shirasawa, T. (2007) The toxic conformation of the 42-residue amyloid β peptide and its relevance to oxidative stress in Alzheimers disease Mini-Rev. Med. Chem. 7, 1001-1008 (Pubitemid 47554768)
11. Murakami, K., Masuda, Y., Shirasawa, T., Shimizu, T., and Irie, K. (2010) The turn formation at positions 22 and 23 in the 42-mer amyloid β peptide: the emerging role in the pathogenesis of Alzheimers disease Geriatr. Gerontol. Int. 10 (Suppl. 1) S169-S179
12. Murakami, K., Horikoshi-Sakuraba, Y., Murata, N., Noda, Y., Masuda, Y., Kinoshita, N., Hatsuta, H., Murayama, S., Shirasawa, T., Shimizu, T., and Irie, K. (2010) Monoclonal antibody against the turn of the 42-residue amyloid β protein at positions 22 and 23 ACS Chem. Neurosci. 1, 747-756
13. Murakami, K., Murata, N., Noda, Y., Tahara, S., Kaneko, T., Kinoshita, N., Hatsuta, H., Murayama, S., Barnham, K. J., Irie, K., Shirasawa, T., and Shimizu, T. (2011) SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease J. Biol. Chem. 286, 44557-44568
14. Chou, P. Y. and Fasman, G. D. (1977) β-Turns in proteins J. Mol. Biol. 115, 135-175
15. Stine, W. B., Jr., Dahlgren, K. N., Krafft, G. A., and LaDu, M. J. (2003) In vitro characterization of conditions for amyloid-β peptide oligomerization and fibrillogenesis J. Biol. Chem. 278, 11612-11622 (Pubitemid 36792723)
16. Sinha, S., Lopes, D. H., Du, Z., Pang, E. S., Shanmugam, A., Lomakin, A., Talbiersky, P., Tennstaedt, A., McDaniel, K., Bakshi, R., Kuo, P. Y., Ehrmann, M., Benedek, G. B., Loo, J. A., Klarner, F. G., Schrader, T., Wang, C., and Bitan, G. (2011) Lysine-specific molecular tweezers are broad-spectrum inhibitors of assembly and toxicity of amyloid proteins J. Am. Chem. Soc. 133, 16958-16969
17. Sinha, S., Du, Z., Maiti, P., Klarner, F.-G., Schrader, T., Wang, C., and Bitan, G. Comparison of three amyloid assembly inhibitors: the sugar scyllo-inositol, the polyphenol epigallocatechin gallate, and the molecular tweezer CLR01. (Published Online Mar 7, 2012) ACS Chem. Neurosci., [Online early access]. DOI: 10.1021/cn200133x.
18. Ono, K., Hamaguchi, T., Naiki, H., and Yamada, M. (2006) Anti-amyloidogenic effects of antioxidants: implications for the prevention and therapeutics of Alzheimers disease Biochim. Biophys. Acta 1762, 575-586 (Pubitemid 43903118)
19. Watson, D. J., Lander, A. D., and Selkoe, D. J. (1997) Heparin-binding properties of the amyloidogenic peptides Aβ and amylin. Dependence on aggregation state and inhibition by Congo red J. Biol. Chem. 272, 31617-31624 (Pubitemid 28013306)
20. Ansari, M. A. and Scheff, S. W. (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex J. Neuropathol. Exp. Neurol. 69, 155-167
21. Ansari, M. A. and Scheff, S. W. (2011) NADPH-oxidase activation and cognition in Alzheimer disease progression Free Radical Biol. Med. 51, 171-178
22. Nunomura, A., Tamaoki, T., Tanaka, K., Motohashi, N., Nakamura, M., Hayashi, T., Yamaguchi, H., Shimohama, S., Lee, H. G., Zhu, X., Smith, M. A., and Perry, G. (2010) Intraneuronal amyloid β accumulation and oxidative damage to nucleic acids in Alzheimer disease Neurobiol. Dis. 37, 731-737
23. Nunomura, A., Tamaoki, T., Motohashi, N., Nakamura, M., McKeel, D. W., Jr., Tabaton, M., Lee, H. G., Smith, M. A., Perry, G., and Zhu, X. (2012) The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons J. Neuropathol. Exp. Neurol. 71, 233-241
24. Himeno, E., Ohyagi, Y., Ma, L., Nakamura, N., Miyoshi, K., Sakae, N., Motomura, K., Soejima, N., Yamasaki, R., Hashimoto, T., Tabira, T., LaFerla, F. M., and Kira, J. (2011) Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation Ann. Neurol. 69, 248-256
25. Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., Greengard, P., and Relkin, N. R. (2000) Intraneuronal Aβ42 accumulation in human brain Am. J. Pathol. 156, 15-20 (Pubitemid 30644433)
26. Jana, A. and Pahan, K. (2004) Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimers disease J. Biol. Chem. 279, 51451-51459 (Pubitemid 40017893)
27. Hansson Petersen, C. A., Alikhani, N., Behbahani, H., Wiehager, B., Pavlov, P. F., Alafuzoff, I., Leinonen, V., Ito, A., Winblad, B., Glaser, E., and Ankarcrona, M. (2008) The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proc. Natl. Acad. Sci. U.S.A. 105, 13145-13150
28. Reddy, P. H. and Beal, M. F. (2008) Amyloid β, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimers disease Trends Mol. Med. 14, 45-53
29. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992) β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity J. Neurosci. 12, 376-389
30. LaFerla, F. M. (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimers disease Nat. Rev. Neurosci. 3, 862-872
31. Resende, R., Ferreiro, E., Pereira, C., and Oliveira, C. R. (2008) ER stress is involved in Aβ-induced GSK-3β activation and tau phosphorylation J. Neurosci. Res. 86, 2091-2099
32. Osakada, F., Hashino, A., Kume, T., Katsuki, H., Kaneko, S., and Akaike, A. (2004) α-Tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons Neuropharmacology 47, 904-915 (Pubitemid 39440984)
33. Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C., and Breteler, M. M. (2002) Dietary intake of antioxidants and risk of Alzheimer disease JAMA, J. Am. Med. Assoc. 287, 3223-3229 (Pubitemid 34686103)
34. Sung, S., Yao, Y., Uryu, K., Yang, H., Lee, V. M., Trojanowski, J. Q., and Pratico, D. (2004) Early vitamin E supplementation in young but not aged mice reduces Aβ levels and amyloid deposition in a transgenic model of Alzheimers disease FASEB J. 18, 323-325
35. Nishida, Y., Ito, S., Ohtsuki, S., Yamamoto, N., Takahashi, T., Iwata, N., Jishage, K., Yamada, H., Sasaguri, H., Yokota, S., Piao, W., Tomimitsu, H., Saido, T. C., Yanagisawa, K., Terasaki, T., Mizusawa, H., and Yokota, T. (2009) Depletion of vitamin E increases amyloid β accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease J. Biol. Chem. 284, 33400-33408
36. Ding, Y., Qiao, A., Wang, Z., Goodwin, J. S., Lee, E. S., Block, M. L., Allsbrook, M., McDonald, M. P., and Fan, G. H. (2008) Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimers disease transgenic mouse model J. Neurosci. 28, 11622-11634
37. Murakami, K., Murata, N., Ozawa, Y., Kinoshita, N., Irie, K., Shirasawa, T., and Shimizu, T. (2011) Vitamin C restores behavioral deficits and Aβ oligomerization without affecting plaque formation in a mouse model of Alzheimers disease J. Alzheimer's Dis. 26, 7-18
38. Leithead, J. A., Simpson, K. J., and MacGilchrist, A. J. (2009) Fulminant hepatic failure following overdose of the vitamin A metabolite acitretin Eur. J. Gastroenterol. Hepatol. 21, 230-232
39. Tomiyama, T., Nagata, T., Shimada, H., Teraoka, R., Fukushima, A., Kanemitsu, H., Takuma, H., Kuwano, R., Imagawa, M., Ataka, S., Wada, Y., Yoshioka, E., Nishizaki, T., Watanabe, Y., and Mori, H. (2008) A new amyloid β variant favoring oligomerization in Alzheimers-type dementia Ann. Neurol. 63, 377-387 (Pubitemid 351499867)
40. Suzuki, T., Murakami, K., Izuo, N., Kume, T., Akaike, A., Nagata, T., Nishizaki, T., Tomiyama, T., Takuma, H., Mori, H., and Irie, K. (2010) E22Δ mutation in amyloid β-protein promotes β-sheet transformation, radical production, and synaptotoxicity, but not neurotoxicity Int. J. Alzheimer's Dis. 2011, 431320
41. Umeda, T., Tomiyama, T., Sakama, N., Tanaka, S., Lambert, M. P., Klein, W. L., and Mori, H. (2011) Intraneuronal amyloid β oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo J. Neurosci. Res. 89, 1031-1042
42. Kume, T., Kouchiyama, H., Kaneko, S., Maeda, T., Akaike, A., Shimohama, S., Kihara, T., Kimura, J., Wada, K., and Koizumi, S. (1997) BDNF prevents NO mediated glutamate cytotoxicity in cultured cortical neurons Brain Res. 756, 200-204 (Pubitemid 27241627)
43. Kume, T., Nishikawa, H., Tomioka, H., Katsuki, H., Akaike, A., Kaneko, S., Maeda, T., Kihara, T., and Shimohama, S. (2000) p75-mediated neuroprotection by NGF against glutamate cytotoxicity in cortical cultures Brain Res. 852, 279-289 (Pubitemid 30035164)
44. Murakami, K., Irie, K., Morimoto, A., Ohigashi, H., Shindo, M., Nagao, M., Shimizu, T., and Shirasawa, T. (2003) Neurotoxicity and physicochemical properties of Aβ mutant peptides from cerebral amyloid angiopathy: implication for the pathogenesis of cerebral amyloid angiopathy and Alzheimers disease J. Biol. Chem. 278, 46179-46187 (Pubitemid 37432769)
45. Alvarez, G., Ramos, M., Ruiz, F., Satrustegui, J., and Bogonez, E. (2003) Pyruvate protection against β-amyloid-induced neuronal death: role of mitochondrial redox state J. Neurosci. Res. 73, 260-269 (Pubitemid 36835427)